• HÁGASE MIEMBRO
    Obtenga acceso total a theheart.org
    Siendo miembro usted podrá ver nuestros videos educativos y editoriales, realizar búsquedas en nuestro sitio web, descargar diapositivas, participar en discusiones, recibir nuestros boletines de noticias y mucho más.

    ¡Asociarse es gratuito!
    benefíciese de 30 días de acceso limitado gratuito para leer las noticias de heartwire
    Profesional de la salud   Si No
The selected article could not be found. Try again later or contact administrator.
Brain/Kidney/Peripheral
Feb 6, 2012 12:30 EST
A new, contemporary study in real-world patients with chronic kidney disease finds that those with systolic BPs of 140 mm Hg and higher are at the greatest risk of developing end-stage renal disease. Hence the current "goal" in CKD patients of 130 mm Hg should be revised upward, say the authors, making the target easier to achieve and allowing physicians to focus on other aspects of care.

San Francisco, CA - A new "real-world" study in chronic kidney disease (CKD) has found that high systolic blood pressure (SBP) seems to account for most of the progression to end-stage renal disease (ESRD) in these patients and that this risk starts at around 140 mm Hg, rather than at 130 mm Hg, which is the current target SBP for CKD [1]. The authors suggest an upward revision of the BP goal for this patient population.

"A more attainable goal among persons with CKD may ease some of the challenges faced by physicians," say Dr Carmen A Peralta (University of California, San Francisco) and colleagues, who report the findings of the Kidney Early Evaluation Program (KEEP), in the January 9, 2012 issue of the Archives of Internal Medicine.
Read full article »

Editorial programs
Debate and dialogue between top cardiovascular specialists, produced by
theheart.org's editorial team
View all »